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Nitric oxide (NO) has been implicated in some of the central pathways engaged in the regulation of the sleep–wake cycle. The existence of
nitric oxide synthase (NOS) in the cholinergic basal forebrain (BF) cells projecting to the cortex suggests a role for NO in the activation
induced by the BF during arousal. We tested, in the anesthetized cat, the hypothesis that inhibition of NOS would decrease the ability of
BF cholinergic fibers to induce cortical activation. In control conditions, BF stimulation evoked an awake-like EEG pattern (i.e., a decrease
in the low-frequency– high-amplitude oscillatory activity and an increase in the high-frequency–low-amplitude activity). After blocking
NOS activity, the capacity of BF stimulation to induce cortical activation was strongly impaired. Furthermore, voltammetric measure-
ments of NO levels revealed an increase in cortical NO after BF stimulation, also blocked by systemic NOS inhibition. These results
indicate that the blockade of NOS activity significantly reduces the ability of BF stimulation to induce changes in the EEG pattern and
suggest a role for NO in the BF– cholinergic system implicated in arousal mechanisms.
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Introduction
How does the brain wake up? This question was first addressed by
Moruzzi and Magoun (1942), who showed that stimulation of
the midbrain reticular formation produced behavioral arousal
and EEG desynchronization. They deduced that the difference
between waking and sleep was caused by intrinsic activity of these
neurons. Evidence now suggests that multiple brainstem and
forebrain cell groups participate in the control of arousal, and
that no single system appears to be necessary for maintenance of
an activated EEG. Two major cell groups use the neurotransmit-
ter acetylcholine (ACh), one localized in the peribrachial region
of the brainstem (projecting to the midbrain, regulating thalamic
excitability) and the second in the basal forebrain (BF) (project-
ing to the entire neocortex, giving rise to phasic activation during
waking states) (for review, see Steriade et al., 1997). Interestingly,
these ACh-containing fibers also contain nitric oxide (NO) syn-
thase (NOS), the enzyme responsible for the production of nitric
oxide (Bickford et al., 1993, 1994).
BF neurons participate in the regulation of cortical activity;
throughout the sleep–wake cycle, the function of the BF– cortical
pathway is complex, and sleep-promoting mechanisms appear to
coexist with mechanisms of arousal or activation (Szymusiak and
McGinty, 1989, 1994; Szymusiak, 1995; Szymusiak et al., 2000).
The portions of the BF involved in the regulation of the sleep–
arousal cycle contain groups of cholinergic neurons projecting
monosynaptically to the entire neocortex and limbic telenceph-
alon, exerting excitatory effects on target cells. Cholinergic cells
are localized in the diagonal band of Broca, the substantia in-
nominata, and the nucleus basalis (NB) of Meynert. The cholin-
ergic cells in the NB, also known as Ch4 neurons (Mesulam et al.,
1983), project to most regions of the neocortex (Adams et al.,
1986; Boylan et al., 1986) and are implicated in cortical arousal
mechanisms and in the control of selective attention (Muir et al.,
1994; Perry et al., 1999). In vivo electrical stimulation of the BF
enhances cortical ACh release (Casamenti et al., 1986; Kurosawa
et al., 1989; Tremblay et al., 1990), eliciting electroencephalo-
graphic activation by depolarizing cortical neurons (Metherate et
al., 1992; Metherate and Ashe, 1993). The activation of this path-
way promotes tonic firing in cortical neurons and generates EEG
patterns characteristic of activated behavioral states, switching
sleep-like activity (high-amplitude, slow-frequency oscillations)
to an awake-like pattern (low-amplitude, fast oscillations). In-
deed, when this pathway is blocked by lesions, the lack of ACh is
associated with a decrease in cortical activation (LoConte et al.,
1982; Stewart et al., 1984). The evidence now suggests, therefore,
that the BF-activating system works by bringing together the
function of ACh and NO, a cooperation that also occurs in the
brainstem, ascending pathways implicated in arousal regulation,
in which NOS is specifically colocalized with the cholinergic
brainstem–thalamic system (Pape and Mager, 1992; Bickford et
al., 1993; Cudeiro and Rivadulla, 1999). NO is now considered an
important modulator of neuronal function (Garthwaite and
Boulton, 1995) and has been implicated in the responsiveness of
visual cortical neurons (Cudeiro et al., 1997). Recent evidence
also indicates that NO may be involved in cortical activation,
disrupting slow oscillations and promoting tonic firing of neu-
rons (Nistico et al., 1994; Cudeiro et al., 2000). In the present
work, we studied the role of NO in cortical arousal induced by the
cholinergic–BF system. We hypothesized that if NO is implicated
in this activating system, we should be able to modify the effect of
BF stimulation on cortical activity by manipulating NO levels
through NOS inhibition.
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Materials and Methods
Experiments were performed on 11 adult cats
of either sex. Anesthesia was induced with ket-
amine (10 –20 mg/kg, i.m.) and maintained
with -chloralose (60 mg/kg, i.v.; n  5) or
ketamine–xylazine (10 –15 mg/kg and 2–3 mg,
i.m.; n  6). Animals were paralyzed (pancu-
ronium bromide, 1 mg  kg1  hr1, i.v.) and
artificially ventilated; the end-tidal CO2 con-
centration was adjusted to 4%, body tempera-
ture was maintained at 37–38°C, and heart rate
was continuously monitored. Animals were
suspended on a stereotaxic frame, and the pres-
sure points were infiltrated with lidocaine. The
depth of anesthesia was maintained by addi-
tional doses of -chloralose or ketamine–xyla-
zine, and particular care was taken to keep a
stable pattern of slow oscillatory activity
throughout the entire experiment. Four
craniotomies were performed to insert record-
ing as well as stimulating electrodes, and all
exposed cortical surfaces were bathed in min-
eral oil or saline to prevent desiccation. The
procedures conformed to the Spanish Physiol-
ogy Society and the International Council for
Laboratory Animal Science and the European
Union (statute 86/809).
Cortical recordings. Cortical activity was con-
tinuously monitored using two different meth-
ods. Focal activity, or electrocorticogram
(ECoG), was recorded through electrodes
(FHC, Bowdoinham, ME) implanted in the
primary somatosensory (S1; coordinates: ante-
rior, 21–23; lateral, 8 –10) and visual (V1; pos-
terior, 0 – 4; lateral, 1–2) cortices at a depth of
1–1.5 mm. In addition, in three experiments,
surface electrodes for EEG recording were
placed on the skull at frontal, parietal, and oc-
cipital areas.
Electrical stimulation. BF neurons were activated by electrical micro-
stimulation at intervals of 5–10 min. Trains of rectangular cathodal
shocks (0.05 msec, 0.1–1 mA) were delivered at a frequency of 50 Hz for
a period of 2– 4 sec through a bipolar electrode (insulated except for 500
m at the tip; contacts separated by 500m) stereotaxically placed at the
following Horsley–Clark coordinates: anterior, 10 –13; lateral, 8.5–10;
ventral, 1– 0. The final position in the vertical axis was adjusted by
stimulating at 0.5 Hz during insertion of the electrode while monitoring
the evoked potential recorded through the recording electrodes previ-
ously placed in S1 (Fig. 1 A). The first clear signal to appear was the field
potential evoked from the internal capsule, which had a fast first compo-
nent, with a latency to the peak of 3– 4 msec [Tremblay et al. (1990),
their Fig. 1]. This potential disappeared as the electrode was advanced
(typically 3– 4 mm above BF region), and a slower waveform, with a
latency of 8 –10 msec, appeared when stimulating around BF stereotaxic
coordinates. In addition, to better localize the optimal position inside the
BF, in four experiments we inserted an array of three stimulating bipolar
electrodes positioned mediolaterally at 500 m separation. In all cases,
the current was adjusted to obtain the minimum intensity capable of
evoking a cortical activation. Usually, stimulating for 2 sec with an inten-
sity of 0.5 mA was enough to achieve the desired effect. Subsequently, to
guarantee an adequate effect on EEG activity throughout the entire ex-
periment, we decided to apply a “suprathreshold” stimulation of 4 sec
duration without increasing the intensity. Repetitive electrical stimula-
tion over several hours may cause electrolytic lesions, reducing the effect
of the stimulus. This was not the case, however, for the stimulus param-
eters used in this study. It is possible to obtain some cortical activation by
means of current spread to the internal capsule, which could have inter-
fered in our results. We tested for this possible artifact in one control
experiment in which we examined the ability to evoke cortical activation
along the entire descending track with various current intensities. After
adjusting the intensity to evoke cortical activation from the BF, the stim-
ulation effect changed significantly4 mm above the BF site, and more
than twice the initial intensity was required to evoke some EEG activa-
tion. This indicates the high power of BF neurons to influence cortical
activity through their highly widespread connections, compared with the
more focal targets of axons running through a local region of the internal
capsule. Thus, BF stimulation provided us with a very reliable tool for
switching cortical activity. To verify the stimulation site histologically,
positive current (100 A, 20 sec) was passed through the stimulation
electrode at the end of the experiment. Animals were perfused with nor-
mal saline followed by 4% paraformaldehyde. Transverse 60 m frozen
sections were cut, serially mounted, and stained with cresyl violet; the
location of the electrode was then determined. Reconstruction of the
electrode tracks (Fig. 1 B) revealed that the tips were located in the BF,
where cholinergic cells projecting to the cerebral cortex in the cat have
been described previously (for comparison, see Bickford et al., 1994).
Pharmacological manipulation. After 60 –90 min of control recordings,
during which BF stimulation induced clear and reproducible cortical
activation, we administered one of two NOS inhibitors. In four experi-
ments (two performed under ketamine– chloralose and two under ket-
amine–xylazine), N G-nitro-L-arginine (L-NOArg, which blocks both iso-
forms of NOS) was locally applied (30 mM, 0.5 l) by microinjection
using a 0.5 l Hamilton syringe. L-NOArg was dissolved in saline and
injected over a period of 40 sec. We injected at four sites, at 1 mm
depth, 1–2 mm around the S1 recording electrode. In seven experiments
(three using ketamine– chloralose and four using ketamine–xylazine),
we used the specific neuronal NOS (nNOS) inhibitor 7-nitroindazole
(7-NI) (80 mg/kg, i.p., which must be suspended in peanut oil) (Burlet et
al., 1999). The injected volume was 6 ml. The possible effects of vehicle
Figure 1. A, Field potentials recorded in S1 evoked by electrical stimulation through a bipolar electrode while it was advanced
from the cortical surface toward the BF. See Materials and Methods for details. The arrow and the vertical line indicate the
beginning of the electrical stimulation. B, Histological localization of BF stimulation sites. The coronal section shows a lesion made
trough the stimulation electrode. Vertical dotted lines mark the track of the bipolar electrode. The open circled area signals
the location of the electrode tips. AC, Anterior commissure; CA, caudate; CC, corpus callosum; CL, claustrum; F, fornix; GP, glo-
bus pallidus; IC, internal capsule; OC, optic chiasm.
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were tested in two animals in the opposite hemisphere to the L-NOArg
injections. All of the chemicals were purchased from Sigma–Aldrich
(Madrid, Spain).
Voltammetric recordings. Two experiments were devoted to the measure-
ment of cortical NO release using voltammetric techniques, in which NO
release is monitored using an electrochemical method, as described previ-
ously (Escrig et al., 1999). Briefly, the procedure derives from the approach
first described by Malinski and Taha (1992). It is on the basis of the catalytic
oxidation of NO on polymeric metalloporphyrins. Differential normal pulse
voltammetry (DNPV) with carbon fiber microelectrodes covered with a
polymeric porphyrin film and coated with a perflourinated polyacid with
cation exchange properties (Nafion) was performed. Voltammetric record-
ings were made with a microprocessor-controlled pontentiostat system
(Bioelectrochemical Analyser; University of La Laguna, Tenerife, Spain).
The following DNPV parameters were used: potential range, 100–1000
mV; scan rate, 10 mV/sec; pulse amplitude, 40 mV; pulse duration, 40 msec;
and prepulse duration, 50–120 msec. Under these conditions, NO solutions
show an oxidation peak at 650 mV. To measure NO release, electrodes
were gently placed on top of the cortex with a micromanipulator and slowly
lowered at a depth of 500 m. NO electrodes were placed in the vicinity of
the recording electrode (2–3 mm apart).
Data acquisition and analysis. ECoG activity was stored unfiltered on
videotape as well as filtered (0.1–100 Hz) on a hard disk through a Digi-
data 1200A board (Axon Instruments, Foster City, CA). EEG activity was
acquired and stored using hardware and software from ATI (Lermed,
Argentina).
In all experiments, the power spectrum relationship of recorded cor-
tical activity was calculated for periods of 5–10 sec immediately before
and after BF electrical stimulation. ECoG recordings were analyzed using
in-house software written in Matlab. Calculation of the fast Fourier
transform (FFT) of ECoG activity was used to obtain the power spectrum
estimate of data sequences. We used Welch’s averaged periodogram
method: nonoverlapping sections of data were windowed (Hanning win-
dow with 1024 or 4096 points) and zero padded to the selected length
(1024 or 4096). The resulting squared magnitudes of the sections were
averaged to form the power spectrum. The statistical significance of the
pharmacologically induced changes was determined using the following
paradigm: After a period in which baseline NO release was observed and
stabilized, electrical stimulation was repeated on a fixed time schedule,
with observations just before; 15 sec after; and2, 4, and 6 min after each
stimulation. With this paradigm, under control conditions, a clear in-
crease in NO was seen at 15 sec immediately after stimulation, falling
back to prestimulation levels by 6 min (see Fig. 5). For statistical analysis,
prestimulation and poststimulation observations for each animal were
compared using the Wilcoxon paired test for each of the predrug and
postdrug periods. p 0.01 was considered statistically significant.
Results
BF stimulation produced changes on cortical activity
Anesthesia induced sleep-like oscillatory activity that could be
modified through electrical stimulation of the BF, giving rise to a
change in the ECoG: Activity shifted from a high-amplitude–
low-frequency to a low-amplitude– high-frequency activity or
awake-like pattern. This result was obtained either with
-chloralose or with ketamine as the anesthetic agent. The
evoked awake-like pattern persisted for a variable period of time,
usually lasting from 2 to 20 sec. Figure 2 is an example of the effect
evoked by stimulation in the BF. We show here the spontaneous
ECoG activity simultaneously recorded through intracranial
electrodes placed in the S1 and V1 and the effect obtained when
the BF region was stimulated (the horizontal bar indicates the
period of BF stimulation). ECoG activity changed dramatically to
the awake-like state.
To test the hypothesis that these effects were attributable to
activation of cholinergic neurons produced by our BF stimula-
tion, in one cat, we repeated the same protocol before and after
systemic administration (0.5 mg/kg) of atropine (Szymusiak et
al., 1990). As has been demonstrated previously, in the control
situation, BF stimulation produced a clear change in the ECoG
activity recorded in both the primary visual cortex and somato-
sensory cortex. This effect is completely abolished when stimula-
tion is performed after atropine injection (data not shown).
Inhibition of NOS activity altered the effects of
BF stimulation
In an initial set of experiments (n 4), we attempted to study the
effect of local blockade of cortical NO production on ECoG ac-
tivity during BF stimulation. An example of the data is shown in
Figure 3, in which a segment of ECoG and the derived power
spectrum are illustrated under control conditions, after L-NOArg
application, and after recovery. Figure 3B represents the power
spectrum obtained immediately after BF stimulation, as marked
by a horizontal line over the ECoG traces. The power spectrum
before stimulation (Fig. 3A) indicates the predominance of low-
frequency– high-amplitude oscillatory activity, which, during the
control period, was abolished and shifted toward high-
frequency–low-amplitude activity after BF stimulation (Fig. 3B,
control). Low amplitude is an inherent feature of high-frequency
brain activity, because of the widespread neural desynchroniza-
tion, and is reflected in low power values in the frequency/power
histograms. Therefore, to reveal changes in the range of high
frequencies, we subtracted the power spectrum data before BF
stimulation from the power spectrum after it. The results ob-
tained are shown in Figure 3C and reveal that under control
conditions (Fig. 3C, control), there is a clear increase in high
frequencies of40 Hz. Local microinjections of the NOS inhib-
itor L-NOArg in S1 clearly reduced the ability of BF stimulation to
shift the ECoG toward awake-like parameters: The ECoG and the
power spectrum (L-NOArg column) reflected the persistence of
low-frequency activity after BF stimulation (Fig. 3B) but failed to
show high-frequency activity (Fig. 3C). This effect was seen
10 –15 min after injection and returned to normal conditions
after 45– 60 min (Fig. 3, recovery). Application of saline did not
modify the effect of BF stimulation (data not shown).
Inhibition of neuronal NOS by 7-nitroindazole prevented
changes in ECoG activity produced by BF stimulation
The systemic application of 7-NI strongly diminished the capac-
ity of BF to modulate cortical activity. Again, this effect was ob-
tained regardless of the type of anesthetic used. Figure 4 (control)
shows an example of the switch from sleep-like (Fig. 4A) to
awake-like (Fig. 4B) ECoG activity by means of BF stimulation.
In all experiments (n 7), after 15– 40 min of 7-NI application,
BF stimulation was not able to modulate cortical activity (Fig. 4,
35 min after 7-NI). The injection of the vehicle alone did not
Figure 2. ECoG activity simultaneously recorded in the S1 and V1 under control conditions
(left) and after electrical stimulation (right) of the BF. The stimulation of the BF for 4 sec (hori-
zontal line) produced a change in ECoG from a sleep-like to a wake-like pattern. In the experi-
ments presented in this work, we compare this cortical modulation with the activity obtained
after blocking of NO production.
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induce any change in the control ECoG activity or in the effect
induced by BF stimulation (data not shown).
To further confirm that the observed lack of effect of BF stim-
ulation was because of inhibition of NO production, we recorded
cortical levels of NO in two cats. The recording of NO by volta-
mmetry indicated an increase in the release of NO after BF stim-
ulation under control conditions. This is illustrated in Figure 5A,
in which we show 2 hr of continuous NO recording extracted
from a single experiment. Each “arrowed” point represents an
NO measurement in which the BF was stimulated (at 50 Hz for 5
sec)15 sec before the NO signal (which appears at 650 mV) was
expected. After 7-NI injection (dotted line), the same protocol
was used, and 40 min later, BF stimulation was unable to in-
crease the levels of NO. NO data in control (n 15 paired obser-
vations; prestimulation and poststimulation) versus NO after
7-NI injection (n 15) were statistically significant ( p 0.01).
Figure 5B shows two superimposed single voltammetric traces.
The BF stimulation increased the NO signal. The blockade of
NOS by 7-NI eliminated this effect and also reduced baseline
levels of NO. These results, obtained in two cats, indicate that BF
stimulation is actually inducing an increase in NO (26%), and
that this release may be reduced by systemic application of 7-NI.
Figure 6 shows the results for each of the two animals, demon-
strating the significant NO release induced by BF stimulation
before administration of 7-NI and the loss of such release after
Figure 3. Power spectrum histograms obtained from periods of 5 sec of activity recorded in S1 under control conditions, after local injection of L-NOArg, and after recovery. The lines above the
ECoG records indicate the periods of the recordings taken for this analysis: 1, Before stimulation; 2, after stimulation. A, Normalized power spectrum histograms computed immediately before
electrical stimulation. B, Power spectrum histograms computed immediately after electrical stimulation in the BF. The slow sleep-like oscillations disappear except during the L-NOArg application
(middle record). C, Histograms computed after subtracting the activity in A from the activity in B. This reveals more clearly that the high-frequency activity elicited under normal conditions by BF
stimulation did not appear under the effect of L-NOArg.
Figure 4. ECoG recordings from S1 under control conditions (left) and 35 min after intraperi-
toneal injection of 7-NI (right). A, A 10 sec recording epoch made immediately before BF stim-
ulation. B, A 10 sec recording epoch made immediately after BF stimulation.
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drug administration. The clear drop in baseline NO release is also
evident.
To better illustrate the effect of 7-NI on cortical activation,
Figure 7 shows the variations obtained during a prolonged exper-
imental period (90 min). The figure shows time–power represen-
tations, divided into low and high ECoG frequencies for clarity.
In each part of the figure, the top illustrates the control situation
(without BF stimulation), and the bottom illustrates the data
obtained with BF stimulation. The arrow marks the time of the
intraperitoneal injection of 7-NI. For low frequencies, the injec-
tion of 7-NI had no effect in the control situation, and the pre-
dominant  activity of 2 Hz observed remains generally un-
changed (Fig. 7, low frequency, top). This dominant slow activity
was abolished by BF stimulation (Fig. 7, bottom, 0 –22 min),
which evoked high-frequency activity of 35 Hz (Fig. 7, high
frequency, bottom). However, the injection of 7-NI (arrows)
produced a clear suppression of the effectiveness of BF stimula-
tion. This is already evident 15 min after 7-NI injection
(minute 34) and became most evident from approximately
minute 45– 65. The ability of BF stimulation to desynchronize the
ECoG disappeared after NOS blockade. This is also illustrated at
the bottom, in which high frequencies are represented. In con-
trols, the injection of 7-NI did not produce any effect but severely
affected the changes obtained with BF stimulation (bottom). The
inset shows two representative traces, one for the control situa-
tion (top) and the other 50 min after injection of 7-NI (the hor-
izontal line indicates BF stimulation).
Figure 8 indicates the mean changes observed throughout the
experiment shown in Figure 7. Power-spectrum histograms were
made computing the mean values of six samples (60 min) before
(control) and after 7-NI application. Data for low and high fre-
quencies are depicted in different histograms. Typically, the
switch in cortical activity was statistically significant for the most
prominent low and high frequencies (in this example,2 and 35
Hz, respectively), but this modulatory function of BF was im-
paired when NOS was blocked (Fig. 7) (after 7-NI).
A summary of our findings is shown in Figure 9. Here, we
represent the percentage change in the FFT power obtained after
BF electrical stimulation. We have grouped the results into six
frequency ranges. In the control situation, low frequencies are
clearly reduced and high frequencies are enhanced (the strongest
effect was detected in the gamma range). These effects are
strongly diminished in the presence on 7-NI.
Figure 5. NO cortical levels as measured by voltammetry (representative sample). A, A 2 hr
period of continuous recording in one animal is shown. Each arrow signals those data points
preceded by BF stimulation (50 Hz/5 sec,15 sec before the NO signal). This segment of the
trace is representative of the data set as a whole, and clearly demonstrates the shift in NO
release (basal and stimulated) after 7-NI administration. B, Representative voltammograms
before and after BF stimulation.
Figure 6. NO cortical levels as measured by voltammetry (full data set). The panels show the
mean SD of all data points recorded over the 8 hr of the experiment in two cats. Data were
obtained under two different conditions, before and after intraperitoneal application of 7-NI.
For each condition, the values immediately before electrical stimulation were compared with
those obtained immediately after stimulation. The observed changes are statistically significant
(Wilcoxon test; p 0.01) only for the predrug condition.
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Discussion
In recent years, the proposed functional role(s) of the BF has
expanded in tandem with increased knowledge of its anatomy
and neurochemistry. This diffuse group or set of groups of cells
was originally considered to be the cholinergic arousal system for
the cerebral cortex. More recent evidence suggests multiple cell
types: not only cholinergic, but also a high proportion of
GABAergic cells, many using an excitatory amino acid neuro-
transmitter (Semba, 2000). These cells are intimately inter-
spersed throughout an elongated bilateral structure that begins
medially at its rostral pole, extending laterally more caudally.
Cells may project to the cerebral cortex, but some may also
project locally. In their projection to the cortex, some authors
suggest that cells may project over wide areas, whereas others suggest
more restricted terminations (Zaborszky et al., 1999; Semba, 2000),
which may in fact reflect multiple roles for the various components
of this heterogeneous structure. Acetylcholine has been implicated
in the transition from sleep to wake, but recently, an active role in the
promotion and maintenance of sleep has also been proposed, as well
as involvement in attention, motivation, and learning (for review,
see Zaborszky et al., 1999; Semba, 2000; Sarter and Bruno, 2000).
Despite this near-exponential expansion in proposed functions, one
facet has remained relatively unchanged: the role of the BF in
arousal, mediated via ACh release within the cortex, enhancing cell
responsiveness and increasing signal-to-noise ratios, shifting the
cortex from the classical sleep slow-wave EEG pattern to the desyn-
chronized waveform of wake and arousal. The high concentration of
cholinergic cells of the Ch4 group at the caudal end of the structure
makes this the logical target for the experimental paradigms we have
reported above. As expected, electrical stimulation of this region
resulted in a shift in recorded EEG, or ECoG, from slow-wave activ-
ity to desynchronous, higher frequency, low-amplitude spectra, as
shown, for example, in Figure 2. Interestingly, our electrical stimu-
lation paradigm induced such changes in widespread cortical re-
gions (S1 and V1, simultaneously). However, we should not suggest
too much about the nonspecificity exhibited (our stimulation pa-
rameters were chosen to maximize activation to test a simple hy-
pothesis); i.e., that some component of this arousal was mediated by
the gaseous neurotransmitter NO.
In the cerebral cortex, neuronal NO may arise from two main
sources: BF terminals (Bickford et al., 1994) and cortical cells
containing NOS (Dawson et al., 1991; Vincent and Kimura,
1992). It is widely accepted that the BF terminals play key roles in
cortical activation (Perry et al., 1999) and in conveying ascending
activation from the brainstem to the neocortex (Szymusiak et al.,
2000). Furthermore, the physiological role of the BF ascending
system covers several fronts, and these neurons have been as-
cribed a variety of behavioral functions, including learning and
memory (Bartus et al., 1982; Fibiger, 1991), sensory processing
(Metherate and Ashe, 1993; Sarter and Bruno, 1997), attention
(Muir et al., 1994; Perry et al., 1999), and control of cortical EEG
patterns (Detari et al., 1999). In fact, it has been reported that in
atropine-treated cats, the EEG becomes synchronized during
quiet waking, with the spectral profile identical to that of non-
rapid-eye-movement sleep (Szymusiak et al., 1990). More im-
portantly to our study, NOS is colocalized with ACh in BF termi-
nals (Bickford et al., 1994). This enzyme can exist in a number of
isoforms (Bredt and Snyder, 1994), of which one, nNOS, is spe-
cific to neurons. We tested the effectiveness of the NOS inhibitor
L-NOArg in altering cortical arousal at a local level, by intracor-
tical injection close to an ECoG recording electrode, and such
injections clearly heavily suppressed the ability of BF stimulation
to change the recorded ECoG. This suppression was attributable
to application of the inhibitor, vehicle alone was ineffective, and
activation of the V1 site was unchanged by injections around S1
(data not shown). However, L-NOArg is a nonspecific inhibitor
of NOS (blocking both the nNOS and endothelial NOS iso-
forms), and the effects described could be the result of, for exam-
ple, local blood-flow shifts or other non-neuronal changes in-
duced by blockade of other isoforms of NOS. To examine this
more specifically, we used 7-NI, considered to be a relatively
selective inhibitor for nNOS in vivo, a compound that is not
water-soluble and therefore was given intraperitoneally in peanut
oil (for review, see Moore and Handy, 1997). Because the effect
was essentially the same (although seen at both recording sites),
Figure 7. Time–power relationships throughout 90 min for the frequencies 0 –22 Hz (top)
and 23– 45 Hz (bottom). The graph was computed taking intervals of 10 sec of activity every 10
min and calculating the FFT for every interval. The resulting color-grid was smoothed using an
interpolation function. The color bar was adjusted to the power scale. The inset shows two
representative traces: control situation (top) and the effect of 7-NI (50 min after injection).
Horizontal bars illustrate BF stimulation. See Results for additional details.
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we are confident that the local application acted via nNOS within
the cortex. At this point, a note of caution must be introduced,
because it has been reported in mice and rats that 7-NI also acts as
a monoaminoxidase inhibitor (Di Monte et al., 1997; Desvignes
et al., 1999). Although in the primary visual cortex, noradrenaline
has been related to specific modulation of visual responses and
plasticity, rather than having a more general modulatory effect
(as we claim here for NO), we cannot completely disregard the
possibility of another type of 7-NI-mediated action, different
from nNOS blockade.
The effect we describe here may be mediated directly through
an action of NO on cortical cells or via a secondary action medi-
ated through Ach. Our methods cannot distinguish between
these options. In several systems, it has been reported that NO
modulates ACh release; in fact, in a recent paper, it was clearly
shown that at the level of the BF, inhibition of NO synthesis
resulted in an increase in ACh release (Vazquez et al., 2002),
although a similar experiment in a different neural structure, the
pontine reticular formation, produced opposite results (Leonard
and Lydic, 1997). These results emphasize, as we have stated, the
importance of taking into account the site of drug action within
the brain. In this scenario, NO production after BF stimulation
(either produced experimentally or, for instance, during arousal)
would lead to ACh release, both directly and via an NO-mediated
pathway. Another explanation for the action of NO seen here is a
straightforward modulation of the cGMP secondary messenger
system. Such cGMP modulation has been widely reported in a
number of brain systems, including the cat visual cortex (Cudeiro
et al., 1997). Because of its gaseous nature, NO can affect the
activity of a relatively large neuronal population by local diffu-
sion, thus being an ideal substance for the activation of an exten-
sive cortical volume, and also affecting the thalamus by means of
extensive corticofugal connections. Thus, the combination of
NO and ACh would produce a widespread tonic excitation dur-
ing the shift from sleep to wake states. This arousal function is
probably different from the excitation induced during active
Figure 8. Power-spectrum histograms representing the mean of six consecutive samples. Black bars correspond to FFT power values computed before BF stimulation, whereas white bars are the
values calculated immediately after stimulation. The differences obtained under control conditions are significant ( p 0.01) for the most prominent low ranges (1.5– 6 Hz; 12–15 Hz, the spindle
range, with expanded view in the inset) and high frequencies (gamma range), whereas after 7-NI, the changes evoked by BF stimulation were not significant except for 3 Hz (note, however, in this
case, p 0.05).
Figure 9. Summary of the results. The plots show the percentage change in FFT power after
BF stimulation. The data are means SEM from six experiments. Only changes obtained in the
control situation are statistically significant.
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waking, because during this attentional process, the BF neurons
are controlled differently (i.e., these cells receive different afferent
regulation, depending on the behavioral state), mediated by the
brainstem ascending systems during arousal and by their telen-
cephalic afferents during attentional functions (Sarter and
Bruno, 2000). A similar collaboration between ACh and NO
seems to operate subcortically. For example, at the level of the
dorsal lateral geniculate nucleus, the transmission of visual infor-
mation is enhanced by the release of both ACh and NO from
parabrachial terminals (Cudeiro and Rivadulla, 1999); NO ac-
tively cooperates with ACh, greatly increasing the activation of
the visual pathway (Cudeiro et al., 1994, 1996, 1997).
We have demonstrated previously that local application of the
NO donor diethylamine-NO or application of 8-bromo-cGMP
(the permeable analog of cGMP), although inducing potent ex-
citation, disrupts the rhythmic activity of cortical neurons (Cud-
eiro et al., 2000). Similarly, local NOS blockade decreased the cell
firing rate without enhancing rhythmic behavior, indicating that
although NO enhances excitability, at the levels found in the
anesthetized animal, it is not involved in the generation or main-
tenance of the powerful oscillatory activity produced by
thalamo– cortico–thalamic networks. In fact, in the present
study, systemic inhibition of NOS, although significantly lower-
ing cortical NO levels, did not affect cortical slow oscillatory ac-
tivity. In conclusion, therefore, we propose that NO release dur-
ing the activation of BF ascending fibers is implicated in the
regulation of sleep–wake states, promoting the switch from the
slow oscillations characteristic of sleep to the high-frequency
tonic activity that occurs during arousal and the awake state. This
suggestion is also supported by the finding that in rats, the highest
NO signal measured in the sleep–wake cycle occurs during the
waking state (Burlet and Cespuglio, 1997; Cespuglio et al., 1998),
and that NOS inhibition reduces wakefulness (Dzoljic and De
Vries, 1994). The very nature of NO, a highly diffusible neuro-
modulator thought to be able to influence 2 million synapses
from a single point source (Wood and Garthwaite, 1994), sug-
gests a powerful, global system to wake up the brain, the dysfunc-
tion of which might be related to sleep disorders.
In conclusion, we propose that NO collaborates with ACh,
after the activation of BF ascending fibers, and induces the switch
from the slow oscillations characteristic of sleep to the high-
frequency tonic activity that occurs in arousal and during the
waking condition. The mechanism by which NO interacts with
the cholinergic system at this level still remains unclear.
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